Key Takeaways
- Smartee Denti-Technology released its 2025 annual review, highlighting significant advancements in clinical efficacy, global supply chain capability, and professional education.
- The company achieved a major milestone with over 100,000 cases of its mandibular repositioning technology, providing real-world evidence for the efficacy of using clear aligners to treat severe jaw discrepancies.
- Smartee expanded its production capacity and partnered with the Straumann Group to provide manufacturing support for ClearCorrect in selected EMEA and APAC markets.
- The company launched two major technological innovations: Smartee Sleep Aligners for sleep apnea treatment and Smartee Live 3D, an AI-driven treatment planning tool.
- Smartee established a dedicated UK subsidiary and inaugurated the European Orthodontic Clinical Support Center to support its growing partner base.
Introduction to Smartee’s 2025 Annual Review
Smartee Denti-Technology has released its 2025 annual review, marking a pivotal year in the company’s history. The review highlights Smartee’s transition from rapid growth to sustained maturity, underscored by advancements in three key pillars: clinical efficacy, global supply chain capability, and professional education. The company’s commitment to innovation and customer satisfaction has enabled it to establish itself as a leader in the digital orthodontics industry.
Clinical Milestones and Academic Recognition
A central achievement of 2025 was the crossing of the 100,000-case threshold for the Smartee GS Mandibular Repositioning technology. This volume represents significant real-world evidence for the efficacy of using clear aligners to treat severe jaw discrepancies, specifically Class II and Class III malocclusions, via mandibular repositioning rather than traditional extraction or surgical mechanics. The Journal of Aligner Orthodontics (JAO) published two separate papers on Smartee’s protocols, further documenting clinical outcomes and solidifying the company’s position as a leader in the field.
Operational Expansion and New Partnerships
In 2025, Smartee expanded its production capacity to meet growing international demand by launching a new 100,000-square-meter intelligent manufacturing campus. The facility features fully automated production lines enhanced with additional modular capabilities and supports both internal product lines and external partners. This production capability was validated in October through a strategic partnership with the Straumann Group, under which Smartee will provide manufacturing support for Straumann’s clear aligner brand, ClearCorrect, in selected EMEA and APAC markets.
Research and Development Breakthroughs
In the fourth quarter of 2025, Smartee diversified its clinical portfolio with two major technological launches aimed at multidisciplinary care and workflow efficiency. The company entered the sleep apnea device market with the launch of the Smartee Sleep Aligner series, designed to treat mild-to-moderate Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS). The series features a patented digital twin-splint locking system for mandibular advancement and an ultra-thin 1mm profile, providing a more comfortable wearing experience than conventional appliances. Additionally, Smartee introduced Live 3D, an AI-driven treatment planning tool that generates initial 3D treatment designs in just 30 minutes, significantly accelerating the total production turnaround time.
Global Footprint and Educational Outreach
To support its growing partner base, Smartee established a dedicated UK subsidiary and inaugurated the European Orthodontic Clinical Support Center in Stoke-on-Trent. This center provides region-specific treatment planning and clinical support, ensuring that digital treatment plans align strictly with local medical standards and biomechanical preferences. Smartee’s commitment to academic exchange remained robust in 2025, with participation in 27 major international congresses and the organization of extensive proprietary training. The company’s "Smartee GS" mandibular repositioning technology lecture series toured 17 cities worldwide, training over 11,000 professionals.
Conclusion and Future Outlook
In conclusion, Smartee Denti-Technology’s 2025 annual review highlights the company’s significant advancements in clinical efficacy, global supply chain capability, and professional education. With its expanded production capacity, strategic partnerships, and innovative technological launches, Smartee is well-positioned for continued growth and success in the digital orthodontics industry. As the company looks to the future, it remains committed to its mission of providing high-quality, patient-centric solutions that improve the lives of individuals around the world. With its strong foundation and dedication to innovation, Smartee is poised to remain a leader in the industry for years to come.